Dr. Richard Guido provides an overview on the the updated consensus guidelines for the management of abnormal cervical cancer screening test and cancer precursors.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Discuss the rationale behind the new ASCCP guidelines
  • Describe familiar with management of patients who's cytology is "lesser abnormality"
  • Discuss the management of an ECC that is CIN1

Reading Resources:

  1. Journal of Lower Genital Tract Disease. April 2013. Pages 1-84.
  2. Khan et. al (2005) JNCI.
  3. Sasieni P, BMJ 2009;339

Disclosures:

Dr. Guido has financial interests with the following any entity or entities producing health care goods or services as indicated below:

  • Grant/Research Support: Ikonosy, Minerva, Halt Co.
  • Other: Board Member - ASCCP

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.075) continuing education units (CEU) which are equivalent to 0.75 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 10/3/2013 | Last Modified On: 10/3/2013 | Expires: 10/3/2014

This course has been expired.